SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di Torino
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the expansion of its relationship with the Città della Salute e della Scienza di Torino located in Turin, Italy. The hospital, which used SOPHiA GENETICS after a public tender in 2021 to optimize workflows and support research in the areas of hereditary cancer, neurological disorders, solid tumors, hematology and rare disease, will further expand its ...
Barbara Pasini Elena Bonfiglioli Kevin Puylaert Research Use Molecular Pathology Laboratory Life Sciences
Source: yahoo.com